Bruker Corporation news

Company’s latest data to be presented on “Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification”

EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 18th Annual PEGS Boston Conference, a protein engineering and cell therapy summit, being held virtually and in person from May 2-6,

Bruker Corporation (NASDAQ:BRKR) today announced that it has appointed Dr. Robert Rosenthal to its Board of Directors, effective immediately.
Dr. Rosenthal currently serves as Chief Executive Officer and as a director for Taconic Biosciences, Inc., a privately-held provider of research models for the pharmaceutical and biotech industry, a position he has held since joining Taconic Biosciences in June 2014.

Prior to joining Taconic Biosciences, D